Aspen Pharmacare Holdings Statistics

Total Valuation

Aspen Pharmacare Holdings has a market cap or net worth of ZAR 75.63 billion. The enterprise value is 99.74 billion.

Market Cap	75.63B
Enterprise Value	99.74B

Important Dates

The next estimated earnings date is Tuesday, December 3, 2024.

Earnings Date	Dec 3, 2024
Ex-Dividend Date	Sep 18, 2024

Share Statistics

Aspen Pharmacare Holdings has 444.21 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	444.21M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	16.14%
Owned by Institutions (%)	57.42%
Float	288.50M

Valuation Ratios

The trailing PE ratio is 17.17 and the forward PE ratio is 9.94.

PE Ratio	17.17
Forward PE	9.94
PS Ratio	1.69
PB Ratio	0.89
P/TBV Ratio	n/a
P/FCF Ratio	24.33
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.48, with an EV/FCF ratio of 32.09.

EV / Earnings	22.65
EV / Sales	2.23
EV / EBITDA	9.48
EV / EBIT	11.22
EV / FCF	32.09

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.43.

Current Ratio	1.81
Quick Ratio	1.06
Debt / Equity	0.43
Debt / EBITDA	3.47
Debt / FCF	11.73
Interest Coverage	3.90

Financial Efficiency

Return on equity (ROE) is 5.15% and return on invested capital (ROIC) is 4.69%.

Return on Equity (ROE)	5.15%
Return on Assets (ROA)	4.06%
Return on Capital (ROIC)	4.69%
Revenue Per Employee	4.91M
Profits Per Employee	483,478
Employee Count	9,350
Asset Turnover	0.33
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.50% in the last 52 weeks. The beta is 0.60, so Aspen Pharmacare Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-0.50%
50-Day Moving Average	18,528.24
200-Day Moving Average	21,302.18
Relative Strength Index (RSI)	24.03
Average Volume (20 Days)	917,243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aspen Pharmacare Holdings had revenue of ZAR 44.71 billion and earned 4.40 billion in profits. Earnings per share was 9.91.

Revenue	44.71B
Gross Profit	19.42B
Operating Income	8.89B
Pretax Income	5.71B
Net Income	4.40B
EBITDA	10.30B
EBIT	8.89B
Earnings Per Share (EPS)	9.91

Full Income Statement

Balance Sheet

The company has 12.34 billion in cash and 36.46 billion in debt, giving a net cash position of -24.12 billion or -54.29 per share.

Cash & Cash Equivalents	12.34B
Total Debt	36.46B
Net Cash	-24.12B
Net Cash Per Share	-54.29
Equity (Book Value)	84.86B
Book Value Per Share	191.04
Working Capital	19.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.23 billion and capital expenditures -3.12 billion, giving a free cash flow of 3.11 billion.

Operating Cash Flow	6.23B
Capital Expenditures	-3.12B
Free Cash Flow	3.11B
FCF Per Share	7.00

Full Cash Flow Statement

Margins

Gross margin is 43.43%, with operating and profit margins of 19.89% and 9.85%.

Gross Margin	43.43%
Operating Margin	19.89%
Pretax Margin	12.78%
Profit Margin	9.85%
EBITDA Margin	23.04%
EBIT Margin	19.89%
FCF Margin	6.95%

Dividends & Yields

This stock pays an annual dividend of 3.59, which amounts to a dividend yield of 2.10%.

Dividend Per Share	3.59
Dividend Yield	2.10%
Dividend Growth (YoY)	4.97%
Years of Dividend Growth	2
Payout Ratio	34.63%
Buyback Yield	n/a
Shareholder Yield	2.10%
Earnings Yield	5.82%
FCF Yield	4.11%

Dividend Details

Stock Splits

The last stock split was on October 6, 2008. It was a forward split with a ratio of 1.0175.

Last Split Date	Oct 6, 2008
Split Type	Forward
Split Ratio	1.0175

Scores

Aspen Pharmacare Holdings has an Altman Z-Score of 2.28. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.28
Piotroski F-Score	n/a